Aldeyra Therapeutics Inc. (ALDX)
NASDAQ: ALDX
· Real-Time Price · USD
5.38
0.08 (1.51%)
At close: Aug 15, 2025, 3:59 PM
5.38
0.00%
After-hours: Aug 15, 2025, 06:33 PM EDT
Aldeyra Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -19,696.8B | -57.7M | -55.85M | -44.8M | -37.87M | -30.01M | -37.54M | -45.69M | -52.06M | -60.85M | -62.02M | -64.88M | -66.12M | -63.27M | -57.78M | -53.31M | -46.39M | -38.98M |
Depreciation & Amortization | -715.72B | 249.9K | 249.62K | 251.72K | 253.73K | 256.44K | 262.78K | 262.95K | 263.27K | 262.94K | 258.71K | 253.34K | 256.38K | 259.06K | 264.18K | 41.32K | 46.09K | 52.04K |
Stock-Based Compensation | 2,420.6B | 6.42M | 7.97M | 5.91M | 3.47M | 3.11M | 5.75M | 9.37M | 10.82M | 10.54M | 8.29M | 6.45M | 5.63M | 6.66M | 7.11M | 7.75M | 8.09M | 7.51M |
Other Working Capital | 2.99M | 4.48M | 7.07M | 9.02M | 3.87M | -4.22M | -2.19M | -7.12M | -7.78M | -3.27M | -2.56M | 44.01K | 7.89M | 12.05M | 6.8M | 4.14M | -1.52M | -5.39M |
Other Non-Cash Items | -3,033B | 768.94K | -1.49M | -2.76M | -2.19M | -1.6M | -1.42M | 330.79K | 299.88K | 276.95K | 283.9K | 304.82K | 322.58K | 347.54K | 409.47K | 2.22M | 2.28M | 2.32M |
Deferred Income Tax | n/a | n/a | n/a | 1.76M | 1.76M | 1.76M | 1.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -479.26K | -483.04K | -503.28K |
Change in Working Capital | 3.77M | 4.55M | 5.91M | 8.96M | 3.86M | -4.37M | 861.18K | -6.33M | -5.93M | -3.44M | -3.44M | 883K | 7.06M | 14.05M | 7.44M | 4.48M | -643.81K | -6.01M |
Operating Cash Flow | -21,024.9B | -45.71M | -43.21M | -30.67M | -30.72M | -30.85M | -30.33M | -42.06M | -46.61M | -53.21M | -56.64M | -56.98M | -52.84M | -41.96M | -42.56M | -39.3M | -37.1M | -35.61M |
Capital Expenditures | n/a | n/a | -3 | -3 | 1.00 | 1.00 | 4.00 | 4.00 | n/a | n/a | -16.32K | -8.51K | -8.51K | -8.51K | n/a | -7.81K | -7.81K | -7.81K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -40,263.7B | -82.25M | -96.92M | -75.35M | -60.61M | -30.38M | n/a | n/a | -4.98M | -34.92M | -92.94M | -92.94M | -87.95M | -58.02M | n/a | -5,776.1B | -5,776.1B | -5,776.1B |
Sales Maturities Of Investments | 47,000B | 75M | 52M | 32M | 12M | n/a | 30M | 57M | 81M | 93M | 63M | 36M | 12M | n/a | n/a | 34,800B | 34,800B | 34,800B |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 30K | 30K | 49.02K | 31.08K | -58.01M | -7.86B | -7.86B | -7.86B | -7.81B | -7.81K | 5.49M | 22.79M |
Investing Cash Flow | 6,736.3B | -7.25M | -44.92M | -43.35M | -48.61M | -30.38M | 30M | 57M | 76.02M | 58.08M | -29.95M | -7.86B | -7.88B | -7.86B | -7.81B | 29,023.9B | 29,023.9B | 29,023.9B |
Debt Repayment | -292.5K | -292.5K | -292.5K | -1.04M | -1.04M | -1.04M | -1.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1,002.8B | n/a | n/a | n/a | -532.95K | -527.66K | -475.1K | -475.1K | 1.25M | 1.25M | 1.22M | 4,684.8B | 4,684.8B | 4,684.8B | 4,684.8B | 4.68M | 5.68M | 5.12M |
Financial Cash Flow | 1,002.8B | 813.2K | -171.42K | -1.19M | -1.31M | -1.3M | -1.27M | -257.91K | 1.25M | 1.25M | 1.22M | 194,496.2B | 194,496.2B | 194,496.3B | 194,496.4B | 194.5M | 220.66M | 112.71M |
Net Cash Flow | 41,241.2B | -42.14M | -128.3M | -115.21M | -120.65M | -112.54M | -1.6M | 14.68M | 30.66M | 6.12M | -85.37M | -112.72M | -128.73M | 20.47M | 151.93M | 155.19M | 189.05M | 99.9M |
Free Cash Flow | -21,024.9B | -45.71M | -43.21M | -30.67M | -30.72M | -30.85M | -30.33M | -42.06M | -46.61M | -53.21M | -56.65M | -56.99M | -52.85M | -41.97M | -42.56M | -39.3M | -37.11M | -35.61M |